Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

966. Grulich AE, Swerdlow AJ, Head J,
Marmot MG (1992). Cancer mortality in
African and Caribbean migrants to England
and Wales. Br J Cancer 66: 905-911.
967. Grundy P, Koufos A, Morgan K, Li FP,
Meadows AT, Cavenee WK (1988). Familial
predisposition to Wilms’ tumour does not
map to the short arm of chromosome 11.
Nature 336: 374-376.
968. Grussendorf-Conen EI (1997).
Anogenital premalignant and malignant
tumors (including Buschke-Lowenstein
tumors). Clin Dermatol 15: 377-388.
969. Guillem P, Delcambre F, Cohen-Solal
L, Triboulet JP, Antignac C, Heidet L,
Quandalle P (2001). Diffuse esophageal
leiomyomatosis with perirectal involvement
mimicking Hirschsprung disease.
Gastroenterology 120: 216-220.
970. Guillou L, Coindre JM, Bonichon F,
Nguyen BB, Terrier P, Collin F, Vilain MO,
Mandard AM, Le Doussal V, Leroux A,
Jacquemier J, Duplay H, Sastre-Garau X,
Costa J (1997). Comparative study of the
National Cancer Institute and French
Federation of Cancer Centers Sarcoma
Group grading systems in a population of
410 adult patients with soft tissue sarcoma.
J Clin Oncol 15: 350-362.
971. Guillou L, Duvoisin B, Chobaz C,
Chapuis G, Costa J (1993). Combined smallcell
and transitional cell carcinoma of the
renal pelvis. A light microscopic, immunohistochemical,
and ultrastructural study of
a case with literature review. Arch Pathol
Lab Med 117: 239-243.
972. Guillou L, Wadden C, Coindre JM,
Krausz T, Fletcher CD (1997). “Proximaltype”
epithelioid sarcoma, a distinctive
aggressive neoplasm showing rhabdoid
features. Clinicopathologic, immunohistochemical,
and ultrastructural study of a
series. Am J Surg Pathol 21: 130-146.
973. Gulley ML, Amin MB, Nicholls JM,
Banks PM, Ayala AG, Srigley JR, Eagan
PA, Ro JY (1995). Epstein-Barr virus is
detected in undifferentiated nasopharyngeal
carcinoma but not in lymphoepithelioma-like
carcinoma of the urinary bladder.
Hum Pathol 26: 1207-1214.
974. Gulmez I, Dogan A, Balkanli S, Yilmaz
U, Karacagil M, Tatlisen A (1997). The first
case of periureteric hibernoma. Case
report. Scand J Urol Nephrol 31: 203-204.
975. Guo Y, Sklar GN, Borkowski A,
Kyprianou N (1997). Loss of the cyclindependent
kinase inhibitor p27(Kip1) protein
in human prostate cancer correlates
with tumor grade. Clin Cancer Res 3: 2269-
2274.
976. Gupta AK, Gupta MK, Gupta K (1986).
Dermoid cyst of the testis (a case report).
Indian J Cancer 23: 21-23.
977. Gustafson H, Tribukait B, Esposti PL
(1982). The prognostic value of DNA analysis
in primary carcinoma in situ of the urinary
bladder. Scand J Urol Nephrol 16:
141-146.
978. Haab F, Duclos JM, Guyenne T, Plouin
PF, Corvol P (1995). Renin secreting
tumors: diagnosis, conservative surgical
approach and long-term results. J Urol 153:
1781-1784.
979. Haas GP, Pittaluga S, Gomella L, Travis
WD, Sherins RJ, Doppman JL, Linehan
WM, Robertson C (1989). Clinically occult
Leydig cell tumor presenting with gynecomastia.
J Urol 142: 1325-1327.
980. Haas JE, Bonadio JF, Beckwith JB
(1984). Clear cell sarcoma of the kidney
with emphasis on ultrastructural studies.
Cancer 54: 2978-2987.
981. Haber DA, Englert C, Maheswaran S
(1996). Functional properties of WT1. Med
Pediatr Oncol 27: 453-455.
982. Habuchi T, Devlin J, Elder PA,
Knowles MA (1995). Detailed deletion
mapping of chromosome 9q in bladder
cancer: evidence for two tumour suppressor
loci. Oncogene 11: 1671-1674.
983. Habuchi T, Kinoshita H, Yamada H,
Kakehi Y, Ogawa O, Wu WJ, Takahashi R,
Sugiyama T, Yoshida O (1994). Oncogene
amplification in urothelial cancers with
p53 gene mutation or MDM2 amplification.
J Natl Cancer Inst 86: 1331-1335.
984. Habuchi T, Luscombe M, Elder PA,
Knowles MA (1998). Structure and methylation-based
silencing of a gene
(DBCCR1) within a candidate bladder
cancer tumor suppressor region at 9q32-
q33. Genomics 48: 277-288.
985. Habuchi T, Ogawa O, Kakehi Y, Ogura
K, Koshiba M, Hamazaki S, Takahashi R,
Sugiyama T, Yoshida O (1993).
Accumulated allelic losses in the development
of invasive urothelial cancer. Int
J Cancer 53: 579-584.
986. Habuchi T, Takahashi R, Yamada H,
Kakehi Y, Sugiyama T, Yoshida O (1993).
Metachronous multifocal development of
urothelial cancers by intraluminal seeding.
Lancet 342: 1087-1088.
987. Habuchi T, Takahashi R, Yamada H,
Ogawa O, Kakehi Y, Ogura K, Hamazaki S,
Toguchida J, Ishizaki K, Fujita J,
Sugiyama T, Yoshida O (1993). Influence
of cigarette smoking and schistosomiasis
on p53 gene mutation in urothelial cancer.
Cancer Res 53: 3795-3799.
988. Habuchi T, Yoshida O, Knowles MA
(1997). A novel candidate tumour suppressor
locus at 9q32-33 in bladder cancer:
localization of the candidate region
within a single 840 kb YAC. Hum Mol
Genet 6: 913-919.
989. Hachicha J, Ben Moussa F, Kolsi R,
Ben Maiz H, Ben Ayed H, Jarraya A
(1989). [Acute renal insufficiency revealing
an acute lymphoblastic leukemia
(apropos of a case)]. Nephrologie 10: 83-
85.
990. Hadaczek P, Podolski J, Toloczko A,
Kurzawski G, Sikorski A, Rabbitts P,
Huebner K, Lubinski J (1996). Losses at 3p
common deletion sites in subtypes of kidney
tumours: histopathological correlations.
Virchows Arch 429: 37-42.
991. Haddad FS, Shah IA, Manne RK,
Costantino JM, Somsin AA (1993). Renal
cell carcinoma insulated in the renal capsule
with calcification and ossification.
Urol Int 51: 97-101.
992. Hafner C, Knuechel R, Stoehr R,
Hartmann A (2002). Clonality of multifocal
urothelial carcinomas: 10 years of molecular
genetic studies. Int J Cancer 101: 1-
6.
993. Hafner C, Knuechel R, Zanardo L,
Dietmaier W, Blaszyk H, Cheville J,
Hofstaedter F, Hartmann A (2001).
Evidence for oligoclonality and tumor
spread by intraluminal seeding in multifocal
urothelial carcinomas of the upper
and lower urinary tract. Oncogene 20:
4910-4915.
994. Haggman MJ, Adolfsson J, Khoury S,
Montie JE, Norlen J (2000). Clinical management
of premalignant lesions of the
prostate. WHO Collaborative Project and
Consensus Conference on public health
and clinical significance of premalignant
alterations in the genitourinary tract.
Scand J Urol Nephrol Suppl 205: 44-49.
995. Haggman MJ, Nordin B, Mattson S,
Busch C (1997). Morphometric studies of
intra-prostatic volume relationships in
localized prostatic cancer. Br J Urol 80:
612-617.
996. Hailemariam S, Engeler DS, Bannwart
F (1998). Significance of Intratubular Germ
Cell Neoplasia (ITGCN) in prepubertal
testes of patients with cryptorchidism (CO):
correlation with clinical reappraisal after
two decades. Mod Pathol 11: 84A.
997. Hailemariam S, Engeler DS, Bannwart
F, Amin MB (1997). Primary mediastinal
germ cell tumor with intratubular germ cell
neoplasia of the testis—further support for
germ cell origin of these tumors: a case
report. Cancer 79: 1031-1036.
998. Haines IE, Schwarz MA, Westmore DD,
Sutherland RC (1985). Rhabdomyosarcoma
in a patient treated for metastatic germ cell
tumour of the testis containing teratoma—
a case report. Aust N Z J Surg 55: 141-143.
999. Haleblian GE, Skinner EC, Dickinson
MG, Lieskovsky G, Boyd SD, Skinner DG
(1998). Hydronephrosis as a prognostic
indicator in bladder cancer patients. J Urol
160: 2011-2014.
1000. Hall BD (1971). Bladder hemangiomas
in Klippel-Trenaunay-Weber syndrome. N
Engl J Med 285: 1032-1033.
1001. Hall GS, Kramer CE, Epstein JI (1992).
Evaluation of radical prostatectomy specimens.
A comparative analysis of sampling
methods. Am J Surg Pathol 16: 315-324.
1002. Hall MC, Sanders JS, Vuitch F,
Ramirez E, Pettaway CA (1998).
Deoxyribonucleic acid flow cytometry and
traditional pathologic variables in invasive
penile carcinoma: assessment of prognostic
significance. Urology 52: 111-116.
1003. Hall MC, Womack S, Sagalowsky AI,
Carmody T, Erickstad MD, Roehrborn CG
(1998). Prognostic factors, recurrence, and
survival in transitional cell carcinoma of the
upper urinary tract: a 30-year experience in
252 patients. Urology 52: 594-601.
1004. Hamers A, de Jong B, Suijkerbuijk RF,
Geurts van Kessel A, Oosterhuis JW, van
Echten J, Evers J, Bosman F (1991). A 46,XY
female with mixed gonadal dysgenesis and
a 48,XY, +7, +i(12p) chromosome pattern in
a primary gonadal tumor. Cancer Genet
Cytogenet 57: 219-224.
1005. Hamilton DL, Dare AJ, Chilton CP
(1996). Multiple neurilemmomas of the
penis. Br J Urol 78: 468-469.
1006. Hamilton I, Reis L, Bilimoria S, Long
RG (1980). A renal vipoma. Br Med J 281:
1323-1324.
1007. Hamm B (1997). Differential diagnosis
of scrotal masses by ultrasound. Eur Radiol
7: 668-679.
1008. Hammerer P, Huland H (1994).
Systematic sextant biopsies in 651 patients
referred for prostate evaluation. J Urol 151:
99-102.
1009. Hammerer PG, McNeal JE, Stamey
TA (1995). Correlation between serum
prostate specific antigen levels and the volume
of the individual glandular zones of the
human prostate. J Urol 153: 111-114.
1010. Hamper UM, Sheth S, Walsh PC,
Epstein JI (1990). Bright echogenic foci in
early prostatic carcinoma: sonographic
and pathologic correlation. Radiology 176:
339-343.
1011. Hamper UM, Sheth S, Walsh PC, Holtz
PM, Epstein JI (1990). Carcinoma of the
prostate: value of transrectal sonography in
detecting extension into the neurovascular
bundle. AJR Am J Roentgenol 155: 1015-
1019.
1012. Hamper UM, Sheth S, Walsh PC,
Holtz PM, Epstein JI (1991). Stage B adenocarcinoma
of the prostate: transrectal
US and pathologic correlation of nonmalignant
hypoechoic peripheral zone
lesions. Radiology 180: 101-104.
1013. Hamper UM, Trapanotto V, Dejong
MR, Sheth S, Caskey CI (1999). Threedimensional
US of the prostate: early
experience. Radiology 212: 719-723.
1014. Han S, Peschel RE (2000). Father-son
testicular tumors: evidence for genetic
anticipation? A case report and review of
the literature. Cancer 88: 2319-2325.
1015. Hankey BF, Feuer EJ, Clegg LX,
Hayes RB, Legler JM, Prorok PC, Ries LA,
Merrill RM, Kaplan RS (1999). Cancer surveillance
series: interpreting trends in
prostate cancer—part I: Evidence of the
effects of screening in recent prostate
cancer incidence, mortality, and survival
rates. J Natl Cancer Inst 91: 1017-1024.
1016. Hansson J, Abrahamsson PA (2001).
Neuroendocrine pathogenesis in adenocarcinoma
of the prostate. Ann Oncol 12
Suppl 2: S145-S152.
1017. Hansson J, Bjartell A, Gadaleanu V,
Dizeyi N, Abrahamsson PA (2002).
Expression of somatostatin receptor subtypes
2 and 4 in human benign prostatic
hyperplasia and prostatic cancer.
Prostate 53: 50-59.
1018. Hara M, Satake M, Ogino H, Itoh M,
Miyagawa H, Hashimoto Y, Okabe M,
Inagaki H (2002). Primary ureteral
mucosa-associated lymphoid tissue
(MALT) lymphoma—pathological and
radiological findings. Radiat Med 20: 41-
44.
1019. Hara S, Ito K, Nagata H, Tachibana
M, Murai M, Hata J (2000). [Choriocarcinoma
of the renal pelvis: a case
report]. Hinyokika Kiyo 46: 117-121.
1020. Harland SJ, Cook PA, Fossa SD,
Horwich A, Mead GM, Parkinson MC,
Roberts JT, Stenning SP (1998).
Intratubular germ cell neoplasia of the
contralateral testis in testicular cancer:
defining a high risk group. J Urol 160: 1353-
1357.
1021. Harms D, Janig U (1986). Germ cell
tumours of childhood. Report of 170 cases
including 59 pure and partial yolk-sac
tumours. Virchows Arch A Pathol Anat
Histopathol 409: 223-239.
1022. Harms D, Kock LR (1997). Testicular
juvenile granulosa cell and Sertoli cell
tumours: a clinicopathological study of 29
cases from the Kiel Paediatric Tumour
Registry. Virchows Arch 430: 301-309.
1023. Harnden P, Eardley I, Joyce AD,
Southgate J (1996). Cytokeratin 20 as an
objective marker of urothelial dysplasia.
Br J Urol 78: 870-875.
1024. Harnden P, Mahmood N, Southgate
J (1999). Expression of cytokeratin 20
redefines urothelial papillomas of the
bladder. Lancet 353: 974-977.
1025. Harnden P, Southgate J (1997).
Cytokeratin 14 as a marker of squamous
differentiation in transitional cell carcinomas.
J Clin Pathol 50: 1032-1033.
1026. Harper ME, Glynne-Jones E,
Goddard L, Thurston VJ, Griffiths K (1996).
Vascular endothelial growth factor (VEGF)
expression in prostatic tumours and its
relationship to neuroendocrine cells. Br J
Cancer 74: 910-916.
1027. Hartge P, Hoover R, West DW, Lyon
JL (1983). Coffee drinking and risk of bladder
cancer. J Natl Cancer Inst 70: 1021-
1026.
References 321